TEVA PHARMACEUTICAL-SP ADR (TEVA) Stock Price, Forecast & Analysis
USA • New York Stock Exchange • NYSE:TEVA • US8816242098
TEVA Key Statistics, Chart & Performance
The current stock price of TEVA is 34.08 USD. In the past month the price increased by 9.2%. In the past year, price increased by 92.22%.
TEVA Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to TEVA. When comparing the yearly performance of all stocks, TEVA is one of the better performing stocks in the market, outperforming 96.11% of all stocks.
TEVA Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to TEVA. TEVA has an excellent profitability rating, but there are concerns on its financial health.
TEVA Financial Highlights
Over the last trailing twelve months TEVA reported a non-GAAP Earnings per Share(EPS) of 2.99. The EPS increased by 17.27% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 8.16% | ||
| ROA | 3.46% | ||
| ROE | 17.81% | ||
| Debt/Equity | 1.89 |
TEVA Forecast & Estimates
7 analysts have analysed TEVA and the average price target is 0.11 USD. This implies a price decrease of -99.68% is expected in the next year compared to the current price of 34.08.
For the next year, analysts expect an EPS growth of -4.58% and a revenue growth 0.34% for TEVA
TEVA Ownership
TEVA Latest News, Press Relases and Analysis
About TEVA
Company Profile
Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. The firm operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Company Info
TEVA PHARMACEUTICAL-SP ADR
124 Dvora Hanevi'a St.
TEL AVIV-YAFO 49131 IL
CEO: Kare Schultz
Employees: 33892
Phone: 97239148213
TEVA PHARMACEUTICAL-SP ADR / TEVA FAQ
What does TEVA do?
Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. The firm operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
What is the stock price of TEVA PHARMACEUTICAL-SP ADR today?
The current stock price of TEVA is 34.08 USD. The price increased by 3.05% in the last trading session.
What is the dividend status of TEVA PHARMACEUTICAL-SP ADR?
TEVA does not pay a dividend.
What is the ChartMill technical and fundamental rating of TEVA stock?
TEVA has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Can you provide the market cap for TEVA PHARMACEUTICAL-SP ADR?
TEVA PHARMACEUTICAL-SP ADR (TEVA) has a market capitalization of 39.09B USD. This makes TEVA a Large Cap stock.
What is the next earnings date for TEVA stock?
TEVA PHARMACEUTICAL-SP ADR (TEVA) will report earnings on 2026-05-05.